The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Is today's one about the broker an indication that something needs to be done to boost the sp or am I reading too much optimism into it?
Hasn't done anything for the sp.
What will shift this back towards the recent highs - if anything?
Positive news if a little scant on detail.
Just when the sp was starting to look a little healthier !
OXB need to streamline the business and perhaps consider mRNA vaccine manufacturing, as there is a global shortage of mRNA vaccine manufacturing capacity.
Taverham: I hope you are right though this para is capable of being read both positively and negatively and what are the implications?
Under the new agreement, manufacturing of vaccines at Oxford Biomedica's world class 84,000 sq. ft manufacturing facility, Oxbox, will be available to AstraZeneca on an as needed basis beyond 2022.
That implies it is not needed now.
Does it mean being kept for them so there are no other uses for it?
How much of the facility is ringfenced and for how long as is Oxb being compensated for that?
More questions than answers. It seems temporarily to have stopped the drop so fingers crossed there is some good news in the wings.
AZ must have an indication from somewhere that their vaccine features in the future plans of at least one jurisdiction - if not why the deal?
“potential future manufacturing opportunities for the AstraZeneca COVID-19 vaccine. “ Better than nothing..
It might be that the vaccine news is already built into the share price now ! The markets and those in the know are bound to be fully aware that there will be no further revenues from Astra hence the massive drop and obvious concern re future costs and Homology.
The Moderna news must mean the end of the AZ vaccine. UK govt supporting Moderna. The article I read mentioned Pfizer but not AZ. I wonder of OXB will say anything or keep us all in the dark for a while longer.
Morning Kern
It has been remarkably quiet on the Oxb front as usual. No word on Homology progress but any rise is welcome. Would reinvest if I could be sure of hitting bottom but wouldn’t everyone. My technology and pharma funds ( in fact all my funds) are dropping like a stone and we aren’t officially in a recession yet.
Interesting and scary times ahead.
Hi Shatter
Nice rise today. Let's hope it is the harbinger of things to come and we get some good news though on what is difficult to see, certainly not AZ as we would have been told by now.
I am still holding.
Who would have thought that the sp would have dropped 75% in less than 10 months! This can be a volatile share but where is the bottom?
Major shareholders don’t always get it right. Some have had quite a chequered past . Vulpes and the Diggles have had a few mishaps over the years. For the sp to drop by over two thirds is not a good investment no matter how you try to paint it. Diggle has stepped away as well.
kernowlad this is your worry then you should sell and move on. Investing s definitely not for you.
Novo, Vulpes and Lion trust increased their stakes in April, insiders bought quite a bit. One should not confuse the SP drop because of fundamentals vs the market cash moves
Really, it is better for you to sell and move on if you believe that it will go "fall away into nothing"
GLA
I think the worry is (at least with me) that it will fail and fall away into almost nothing.
Where is the revenue coming from to support its activities?
Why the silence on AZ when everyone must be assuming the deal is dead?
etc etc
so take what you can when you can
Hawkander Really????? you sold at 5y low..... you may have been desperate for money then.
I must admit that after I don`t know how many years, I sold my remaining shares, may return at some later date. GLA
This is very unpleasant to watch. Nothing from the company to even attempt to turn it around. Mind you statements don't always do any good as the CEO of Angle just proved managing to knock off all the gains from being FDA approved and then some by saying there is no short term income and he doesn't want short-term investors. Down from 158 to about 103. Even more ouch.
"Can lead" or does lead? "Can lead" is newspaper headline stuff. How much of an increased risk? A relative risk or an absolute risk? Would be good to know.
The AstraZeneca coronavirus vaccine may lead to an increased risk of developing the serious neurological condition Guillain-Barré Syndrome (GBS), which can lead to the rare and terrifying "locked-in" syndrome.
This is one of those shares that will perform over the long term remember the markets are down and may go lower but good companies like Oxford will come through . Now’s the time to think long term holds rather than short term gains . Be patient. Oxford nano, gsk , Abcam, AstraZeneca is a bit high for my liking. Don’t get despondent market is in bear territory but will turn when ? Not soon . but maybe look at bank shares now . Good luck guys.
Well done on Angle. Looks like Oxb is set to depart the ftse 250 next month. Should be built into the sp as it is no surprise now.
I wish I had sold instead of buying. Will hang on and see what happens but I agree that if the AZ deal was ongoing they would have announced it by now.
Have a reasonable amount in Aviva but just did well in Angle today which announced FDA approval for its system - up 55% atm - and should climb higher as income rolls in. You win some and you lose some!